The Nifty opened at 14604.15 with a gap up of 108 points. The index first traded sideways and recorded its intraday low at 14506.60. Prices have filled the morning gap in the first half and then rallied which lasted towards the end of the day’s trading session. Prices have recorded its intraday at 14637.90 and finally closed at 14617.85 with a gain of 121.35 points. All the sectoral indices have closed in green except realty. The Pharma and Financials have led the bulls. Nifty traded volatile for yet another day but managed to end higher above 14600. After the morning gap up, the Nifty hovered in a range for the first half but saw a sustained rally in the second half aided the index to close around the day high. The Pharma sector outshines and ended with a gain of more than 4%. Banks and Financials also contributed to the upside. The last few days have been very volatile.
We should look for an intraday trade for today. Buy above 14650 or sell short below 14500. Keep a stop of 40 points and a target of 80 points.
Bank Nifty opened at 32577.10 with a gap up of 284 points. The index first consolidated and filled the gap as the index made its intraday low at 32068.55. Price then moved up and continued that momentum for the rest of the day. Private and PSU Banks both have performed the same and closed with a gain of almost 1.5%. Within the index, Indusind Bank contributed highest while Bandhan Bank the lowest.
It was a tale of two halves. The first was sideways while second was bullish. The index ended with a gain of more than 1.5%.
Trade AnyTime AnyWhere With Elite Empower Mobile App
|KOTAK BANK||1770.75||BUY||The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 1755 and for the target 1800|
|AUROPHARMA||1032||BUY||The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 1015 and for the target 1055|
Get All Your Mutual Fund Portfolio Retuns on Your Mobile by Elite Kuber App
|STOCK OPTION||Strike Price||Buy/Sell||CMP||Initiation||Stop Loss||Target||Remarks|
|AXISBANK||720 CE||BUY||25.50||CMP||20||32||OI increase|
|Long Buildup||Short Buildup|
|Stocks||Price||Price%||OI %||OI||Stocks||Price||Price%||OI %||OI|
|VEDL.21.05 May||269.9||3.77||42.21||100923600||BANDHANBNK.21.05 May||311.5||-2.29||22.56||20399400|
|AARTIIND.21.05 May||1720||5.24||26.99||737800||M&MFIN.21.05 May||156||-0.19||20.14||24244000|
|PIIND.21.05 May||2710||8.15||18.55||527250||PNB.21.05 May||37.25||-1.06||12.49||216480000|
|LUPIN.21.05 May||1211.65||14.12||18.53||9908450||APLLTD.21.05 May||963.5||-4.75||12.45||1272150|
|SRF.21.05 May||6957.9||3.07||18.14||613750||GODREJPROP.21.05 May||1226.95||-4.43||10.57||1726400|
|Short Covering||Long Unwinding|
|Stocks||Price||Price%||OI%||OI||Stocks||Price||Price %||OI %||OI|
|FINNIFTYW.21.05 May||15698.45||1.44||-75.91||6920||SIEMENS.21.05 May||1840.7||-2.12||-7.76||879175|
|AMBUJACEM.21.05 May||312.65||1.49||-3.74||17775000||NAM-INDIA.21.05 May||340.65||-0.03||-0.42||1529600|
Get Stock Market Recommendation By Our Research Analysts
TOP DELIVERY PERCENTAGE
|Stocks||Price||%Chg||Total Qty||Delivery||Del %||% Change|
|City Union Bank Ltd.||169.8||1.71||3330540||3653779||80.68||Nifty Pharma||13779.7||4.12||94332|
|Hcl Technologies Ltd.||909.4||0.94||2696835||4062318||65.34||Nifty Metal||4970.15||0.99||94332|
|Tech Mahindra Limited||960.4||0||3041045||2571308||63.27||Nifty 50||14617.85||0.84||94332|
|Nippon Life India Asset||339.1||-0.29||307449||349692||60.23||Nifty Auto||9643.05||0.68||94332|
|Infosys Limited||1341.5||0.91||3939788||2857619||58.47||Nifty Energy||18058.8||0.62||94332|
|Hdfc Ltd.||2377.6||0.02||3458463||1714470||54.67||Nifty Media||1532.25||0.43||94332|
|Hindustan Unilever Ltd||2394.65||-0.54||1256857||772815||53.18||Nifty Fmcg||33898||0.22||94332|
|Colgate Palmolive (india||1493.6||0.19||321141||290955||52.6||Nifty Realty||303.2||-1||94332|
UPCOMING ECONOMIC DATA
|INR: Bank Loan Growth on 7th May, 2021
INR: Deposit Growth on 7th May, 2021
|•USD: Initial Jobless Claims on 6th May, 2021
•USD : Nonfarm Payrolls (Apr) on 7th May, 2021
|•The Cabinet Committee on Economic Affairs (CCEA) has approved strategic disinvestment along with transfer of management control in IDBI Bank, paving the way for both the government, and Life Insurance Corporation of India (LIC) to reduce their shareholding in the lender. LIC’s Board has passed a resolution to reduce its shareholding in the bank along with government’s stake sale plan “with an intent to relinquish management control and by taking into consideration price, market outlook, statutory stipulation and interest of policy holders.”
•Adani Enterprises on Wednesday reported 282.2 per cent rise in consolidated net profit at Rs 233.95 crore for the quarter ended March 31, 2021. The company had posted a consolidated net profit attributable to the owners of the company of Rs 61.21 crore in the year-ago period, Adani Enterprises Ltd (AEL) said in a filing to BSE. The consolidated income of the company during the January-March quarter was at Rs 13,688.95 crore as compared with Rs 13,698.09 crore in the year-ago period, the filing said.
•S&P Global Ratings on Wednesday slashed India’s GDP growth forecast for the current financial year to 9.8 per cent saying the second COVID wave may derail a budding recovery in the economy and credit conditions.The US-based rating agency in March had a 11 per cent GDP growth forecast for India for the April 2021-March 2022 fiscal.
•In a bid to boost India’s health infrastructure amid the second COVID-19 wave, the Reserve Bank of India on May 5 announced an on-tap liquidity window of Rs 50,000 crore with the tenor of up to three years at repo rate. The facility will be available till March 31, 2022
•Source: Economic Times, Indian Express ,Business Today, Livemint, Business Standard, Bloomberg Quint
|Company Name||Purpose||Ex-Date||Company Name||Purpose||Ex-Date|
|ADANIPOWER||Audited Results||06-May-21||FIVEXTRADE||Audited Results;General||06-May-21|
|ADANITRANS||A.G.M.;Quarterly Results||06-May-21||FOSECOIND||Quarterly Results||06-May-21|
|APCOTEXIND||Final Dividend;Quarterly Results||06-May-21||HEROMOTOCO||Final Dividend;Audited Results||06-May-21|
|ASHIKACR||Dividend;Quarterly Results||06-May-21||HIKAL||Final Dividend;Audited Results||06-May-21|
|BBTC||Dividend;Audited Results||06-May-21||HINDMILL||Audited Results||06-May-21|
|BLUESTARCO||Final Dividend;Audited Results||06-May-21||ICRA||Dividend;Audited Results||06-May-21|
|CAPPL||Interim Dividend;Audited Results||06-May-21||IIFL||Audited Results;General||06-May-21|
|CENTURYTEX||Dividend;Audited Results||06-May-21||JOSTS||Final Dividend;Results||06-May-21|
|COFORGE||Interim Dividend;Audited Results||06-May-21||LUDLOWJUT||Dividend;Audited Results||06-May-21|
|CREDITACC||Audited Results||06-May-21||PGHL||Quarterly Results||06-May-21|
|DHANADACO||General||06-May-21||PRAJIND||Final Dividend;Audited Results||06-May-21|
|Company Name||Ex-Date||Purpose||Company Name||Ex-Date||Purpose|
|ALLSEC||06-May-21||Interim Dividend – Rs. – 15.00||VAIBHAVGBL||07-May-21||Stock Split From Rs.10/- to Rs.2/-|
|APTECHT||06-May-21||Interim Dividend – Rs. – 2.2500||ALKYLAMINE||11-May-21||Stock Split From Rs.5/- to Rs.2/-|
|EMBASSY||06-May-21||Income Distribution (InvIT)||LAURUSLABS||11-May-21||Interim Dividend – Rs. – 0.8000|
|PRIMEFRESH||06-May-21||Bonus issue 2:1||PGHH||11-May-21||Special Dividend – Rs. – 150.00|
|SEZAL||07-May-21||Resolution Plan -Suspension||GILLETTE||12-May-21||Interim Dividend|
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, firstname.lastname@example.org
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.Company-Specific Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in , or e-mailing email@example.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail firstname.lastname@example.org.Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.